Augmenix Adds $3M

Xconomy Boston — 

Augmenix, a Waltham, MA-based maker of hydrogel implants for reducing the side effects of radiation therapy, has raised $3 million in an equity and debt financing round, according to an SEC filing. The filing does not list the investors. Some of the firm’s previous backers include Catalyst Health Ventures, Pinnacle Ventures, and Versant Ventures. Last year the firm revealed that its SpaceOAR System, which has gained commercial clearance in Europe, was used in a radiation procedure in Germany.